Delivery Order 36C25221D0064-36C25222N0050

Award Date 10/1/21

Potential Completion Date 7/22/22

Potential Value $453K

Federal Agency

Veterans Integrated Service Network 12

Awardee

Sofie CO. JV1AHJHGUGG3

Ultimate Awardee

Sofie Biosciences, Inc. Z1ZFWF2N1YD4

NAICS Category

325411 - Medicinal and Botanical Manufacturing

PSC Category

6505 - Drugs And Biologicals

Federal Contract Vehicle

Not listed

Set-Aside Type

No Set-Aside Used

Extent Competed

Not Competed under SAP

Major Defense Program

Not listed

Pricing Type

Firm Fixed Price

Place of Performance

Sterling, VA, USA

Solicitation Procedures

Simplified Acquisition

Number Of Offers Received

Not listed

Legislative Mandate

Not listed

National Interest Action

Not listed

Research Type

Not listed

Primary Consortia Member

Not listed

Sofie Co., a subsidiary of Sofie Biosciences, Inc., was awarded a $453,128 firm fixed price delivery order against the VHA Pharmaceutical Prime Vendor contract to provide Pylarify Piflufolastat F18 radiopharmaceuticals for the Veterans Integrated Service Network 12 region. The one year contract runs from October 2021 through July 2022 and has no set aside designation. The Department of Veterans Affairs Veterans Health Administration will utilize the radiopharmaceuticals in medical imaging procedures to support care for veterans served by the regional Veterans Affairs facilities. Sofie will perform under the contract from its production facility in Sterling, Virginia.

Generated 1/2/24, 1:41 PM

Mod #	ReasonForModification	Federal Obligation	Date
P00002	Other Administrative Action	($99k)	12/8/22
P00001	Other Administrative Action	$237.7k	4/15/22
Not listed	Not listed	$314.6k	10/1/21